Login Register Cart 0
Generic placeholder image

Current Molecular Pharmacology

Editor-in-Chief

ISSN (Print): 1874-4672
ISSN (Online): 1874-4702

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Molecular Insights into Agonist/Antagonist Effects on Macromolecules Involved in Human Disease Mechanisms

Author(s): Chandrabose Selvaraj, Sugunadevi Sakkiah and Dhurvas Chandrasekaran Dinesh

Volume 15, Issue 2, 2022

Article ID: e170322202343 Pages: 2

DOI: 10.2174/1874467215999220317164522

[1]
Kumar, A.; Balbach, J. Inactivation of parathyroid hormone: perspectives of drug discovery to combating hyperparathyroidism. Curr. Mol. Pharmacol., 2021, 15(2)
[http://dx.doi.org/10.2174/1874467214666210126112839]
[2]
Girija, A.; Vijayanathan, M.; Sreekumar, S.; Basheer, J.; Menon, T.G.; Krishnankutty, R.E.; Soniya, E.V. Harnessing the natural pool of polyketide and non-ribosomal peptide family: A route map towards novel drug development. Curr. Mol. Pharmacol., 2021, 15(2)
[http://dx.doi.org/10.2174/1874467214666210319145816]
[3]
Sikdar, A.; Gupta, R.; Boura, E. Reviewing Antiviral Research Against Viruses Causing Human Diseases - A Structure Guided Approach. Curr. Mol. Pharmacol., 2021, 15(2)
[http://dx.doi.org/10.2174/1874467214666210804152836]
[4]
Precilla, D.S.; Kuduvalli, S.S.; Purushothaman, M.; Marimuthu, P.; Ramachandran, M.A.; Anitha, T.S. Wnt/beta-catenin Antagonists: Exploring New Avenues to Trigger Old Drugs in Alleviating Glioblastoma Multiforme. Curr. Mol. Pharmacol., 2021, 15(2)
[http://dx.doi.org/10.2174/1874467214666210420115431]
[5]
Durairajan, S.S.K.; Selvarasu, K.; Bera, M.R.; Rajaram, K.; Iyaswamy, A.; Li, M. Alzheimer’s Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-Derived Compounds in Alleviating Tau-Mediated Neurodegeneration. Curr. Mol. Pharmacol., 2021, 15(2)
[http://dx.doi.org/10.2174/1874467214666210906125318]
[6]
Sindhu, T.; Debnath, P. Cytochrome bc1-aa3 oxidase supercomplex as emerging and potential drug target against tuberculosis. Curr. Mol. Pharmacol., 2021, 15(2)
[http://dx.doi.org/10.2174/1874467214666210928152512]
[7]
Bhavaniramya, S.; Ramar, V.; Vishnupriya, S.; Palaniappan, R.; Sibiya, A.; Baskaralingam, V. Comprehensive analysis of SARS-COV-2 drug targets and pharmacological aspects in treating the COVID-19. Curr. Mol. Pharmacol., 2021, 15(2)
[http://dx.doi.org/10.2174/1874467214666210811120635]
[8]
Selvaraj, C.; Dinesh, D.C.; Krafcikova, P.; Boura, E.; Aarthy, M.; Pravin, M.A.; Singh, S.K. Structural Understanding of SARS-CoV-2 Drug Targets, Active Site Contour Map Analysis and COVID-19 Therapeutics. Curr. Mol. Pharmacol., 2021, 15(2)
[http://dx.doi.org/10.2174/1874467214666210906125959]

Rights & Permissions Print Cite
Article Metrics
22
1
© 2024 Bentham Science Publishers | Privacy Policy